PRMT5 and ovarian cancer: While no clinical trial of a PRMT5 inhibitor for ovarian cancer has been initiated, several studies have demonstrated the inhibition of ovarian cancer cell growth and induction of apoptosis with PRMT5 inhibition or siRNA knockdown.